L-Alanine,N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-, 1-methylethyl ester, (2E)-2-butenedioate (2:1)
CAS:1392275-56-7
Chemical Formula:C25H33N6O9P
Molecular Weight:592.55
Availability: R&D; Commercialization
⬤ CAS No.1392275-56-7
⬤ Packaging type：20kg barrel；5kg barrel；1kg bag；500g bag ; Customized Packaging
| Product Name | Tenofovir alafenamide hemifumarate |
| CAS No. | 1392275-56-7 |
| Chemical Formula | C25H33N6O9P |
| Molecular Weight | 592.55 |
| EINECS | 805-448-8 |
| Related Categories | API; Pharmaceuticals; Antiviral drugs |
| Storage conditions | Keep in dark place,Sealed in dry,Room Temperature |
| Solubility | DMSO: 75.0 (maximum concentration mg/mL); 70.16 (maximum concentration mM) |
| Form | Solid |
| Color | White to off-white |
| Side Effects | The use of tenofovir alafenamide hemifumarate may cause adverse reactions such as headache, vomiting, diarrhea, fatigue, stomach discomfort, increased liver enzymes, and increased blood sugar. |
| Kidney problems | The drug has been shown to cause kidney problems, including acute kidney failure, kidney stones, and renal tubular damage, so patients who take it long-term should have their kidney function checked regularly. |
| Application | Tenofovir alafenamide fumarate can be used as a solvent, catalyst for alkylation, esterification and polymerization reactions. Most of the product is mainly used in medicine. |
Exceptional Product Quality
“We have been sourcing pharmaceuticals from Tianming Pharmaceutical for several years now, and their product quality has consistently exceeded our expectations. Each batch undergoes rigorous testing, ensuring we receive only the highest quality products. This reliability has significantly contributed to our trust and satisfaction with their services. Highly recommended!”
June 15, 2023
Outstanding Technical Guidance
“The technical guidance provided by Tianming Pharmaceutical’s team has been invaluable to our research and development projects. Their experts are knowledgeable, responsive, and always willing to assist with detailed explanations and support. Their guidance has enabled us to optimize our processes and achieve remarkable results. We couldn’t ask for a better partner.”
June 15, 2023
Superior Service Experience
“Our experience with Tianming Pharmaceutical has been nothing short of excellent. Their customer service team is exceptionally responsive and dedicated to meeting our needs. From initial consultation to after-sales support, they have provided seamless, professional service. Their commitment to customer satisfaction is truly commendable.”
June 15, 2023
Precise Product Specifications
“Tianming Pharmaceutical has impressed us with their adherence to precise product specifications. Each order is meticulously packaged and delivered exactly as requested, ensuring that we receive products that perfectly meet our requirements. Their attention to detail and commitment to accuracy have made them a trusted supplier for our business.”
June 15, 2023
Regulatory differences between API and intermediate manufacturing under ICH Q7, FDA, EMA, and NMPA. GMP boundaries, DMF filing, starting material justification.
Finerenone drug class: third‑generation non‑steroidal MRA. Compare selectivity, potency, half‑life, and safety vs spironolactone/eplerenone. FDA‑approved for CKD+T2D and HF with LVEF ≥40%.
Finerenone mechanism of action: a non‑steroidal mineralocorticoid receptor antagonist with high MR selectivity, balanced cardiorenal distribution, no active metabolites, and lower hyperkalemia risk vs steroidal MRAs.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.
